These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20458651)

  • 1. 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review.
    Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
    Swiss Med Wkly; 2010 May; 140(21-22):297-306. PubMed ID: 20458651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
    Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
    Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin.
    Buksnys T; Armstrong N; Worthy G; Sabatschus I; Boesl I; Buchheister B; Swift SL; Noake C; Huertas Carrera V; Ryder S; Shah D; Liedgens H; Kleijnen J
    Curr Med Res Opin; 2020 Jan; 36(1):101-115. PubMed ID: 31469302
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
    van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
    Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
    Rehm S; Binder A; Baron R
    Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M; Liedgens H; Nuijten M
    Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments.
    Überall M; Bösl I; Hollanders E; Sabatschus I; Eerdekens M
    BMJ Open Diabetes Res Care; 2022 Nov; 10(6):. PubMed ID: 36368741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients.
    Hussain N; Said ASA; Javaid FA; Al Haddad AHI; Anwar M; Khan Z; Abu-Mellal A
    J Diabetes Metab Disord; 2021 Jun; 20(1):271-278. PubMed ID: 34178837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
    Liedgens H; Hertel N; Gabriel A; Nuijten M; Dakin H; Mitchell S; Nautrup BP
    Clin Drug Investig; 2008; 28(9):583-601. PubMed ID: 18666805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.
    Katz P; Pegoraro V; Liedgens H
    Curr Med Res Opin; 2017 Aug; 33(8):1481-1489. PubMed ID: 28537441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry.
    Überall MA; Eerdekens M; Hollanders E; Bösl I; Sabatschus I
    Pain Manag; 2022 Mar; 12(2):195-209. PubMed ID: 34372662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic painful neuropathy: current and future treatment options.
    Chong MS; Hester J
    Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.
    Amato F; Duse G; Consoletti L; Lo Presti C; Firetto V; Ciliberto G; Parigi LA; Palmieri V; Mazza M
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4228-4235. PubMed ID: 29028074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.
    Huffman C; Stacey BR; Tuchman M; Burbridge C; Li C; Parsons B; Pauer L; Scavone JM; Behar R; Yurkewicz L
    Clin J Pain; 2015 Nov; 31(11):946-58. PubMed ID: 25565583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
    Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
    Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
    Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
    Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.